Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1990 Sep;87(17):6733–6737. doi: 10.1073/pnas.87.17.6733

Prolactin effects on the dietary regulation of mouse mammary tumor virus proviral DNA expression.

N Hamada 1, R W Engelman 1, Y Tomita 1, R F Chen 1, H Iwai 1, R A Good 1, N K Day 1
PMCID: PMC54611  PMID: 1975696

Abstract

Chronic energy-intake restriction inhibits mouse mammary tumor virus (MMTV)-induced mammary tumors in C3H/Ou mice by greater than 90%. We have shown that associated with suppression of mammary tumorigenesis there is a reduction or inhibition of circulating prolactin, MMTV particles expressed, and MMTV mRNA transcription in mammary glands (and in most organs tested). To understand the concerted action of prolactin, energy-consumption level, and MMTV on inducing mammary tumors, experiments were designed to control prolactin and energy levels in order to evaluate their effects on MMTV mRNA expression. Mice on restricted diets were grafted with adenohypophyses, and mice fed ad libitum were treated with the dopaminomimetic agent octahydrobenzo [g]quinoline. Adenohypophyseal grafting significantly increased prolactin in dietary (energy)-restricted mice, and this effect was associated with an increase in MMTV mRNA expression within the mammary gland; a linear correlation between prolactin levels and MMTV mRNA expression in the mammary gland was found. Conversely, elimination of the nocturnal peak of circulating prolactin by i.p. injection of dopaminomimetic octahydrobenzo [g]quinoline to mice fed ad libitum delayed (by 8 weeks) and reduced (even as long as 25 weeks) mammary gland MMTV mRNA expression. These findings associate prolactin influences with MMTV mRNA production in mice and help explain the link between chronic energy-intake restriction and reduced MMTV gene expression.

Full text

PDF
6733

Images in this article

6735Image
on p.6735
6735Image
on p.6735
6735Image
on p.6735
6736Image
on p.6736

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chen R. F., Good R. A., Engelman R. W., Hamada N., Tanaka A., Nonoyama M., Day N. K. Suppression of mouse mammary tumor proviral DNA and protooncogene expression: association with nutritional regulation of mammary tumor development. Proc Natl Acad Sci U S A. 1990 Apr;87(7):2385–2389. doi: 10.1073/pnas.87.7.2385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  3. Engelman R. W., Day N. K., Chen R. F., Tomita Y., Bauer-Sardiña I., Dao M. L., Good R. A. Calorie consumption level influences development of C3H/Ou breast adenocarcinoma with indifference to calorie source. Proc Soc Exp Biol Med. 1990 Jan;193(1):23–30. doi: 10.3181/00379727-193-42984. [DOI] [PubMed] [Google Scholar]
  4. Fishman J., Fukushima D., O'Connor J., Rosenfeld R. S., Lynch H. T., Lynch J. F., Guirgis H., Maloney K. Plasma hormone profiles of young women at risk for familial breast cancer. Cancer Res. 1978 Nov;38(11 Pt 2):4006–4011. [PubMed] [Google Scholar]
  5. Hill P., Garbaczewski L., Helman P., Walker A. R., Garnes H., Wynder E. L. Environmental factors and breast and prostatic cancer. Cancer Res. 1981 Sep;41(9 Pt 2):3817–3818. [PubMed] [Google Scholar]
  6. Hill P., Wynder E. L., Kumar H., Helman P., Rona G., Kuno K. Prolactin levels in populations at risk for breast cancer. Cancer Res. 1976 Nov;36(11 Pt 1):4102–4106. [PubMed] [Google Scholar]
  7. Levin P. A., Malarkey W. B. Daughters of women with breast cancer have elevated mean 24-hour prolactin (PRL) levels and a partial resistance of PRL to dopamine suppression. J Clin Endocrinol Metab. 1981 Jul;53(1):179–183. doi: 10.1210/jcem-53-1-179. [DOI] [PubMed] [Google Scholar]
  8. Majors J. E., Varmus H. E. Nucleotide sequences at host-proviral junctions for mouse mammary tumour virus. Nature. 1981 Jan 22;289(5795):253–258. doi: 10.1038/289253a0. [DOI] [PubMed] [Google Scholar]
  9. Murphy L. J., Tachibana K., Friesen H. G. Stimulation of hepatic insulin-like growth factor-I gene expression by ovine prolactin: evidence for intrinsic somatogenic activity in the rat. Endocrinology. 1988 May;122(5):2027–2033. doi: 10.1210/endo-122-5-2027. [DOI] [PubMed] [Google Scholar]
  10. Muñoz B., Bolander F. F., Jr Prolactin regulation of mouse mammary tumor virus (MMTV) expression in normal mouse mammary epithelium. Mol Cell Endocrinol. 1989 Mar;62(1):23–29. doi: 10.1016/0303-7207(89)90109-3. [DOI] [PubMed] [Google Scholar]
  11. Nusse R., van Ooyen A., Rijsewijk F., van Lohuizen M., Schuuring E., van't Veer L. Retroviral insertional mutagenesis in murine mammary cancer. Proc R Soc Lond B Biol Sci. 1985 Oct 22;226(1242):3–13. doi: 10.1098/rspb.1985.0075. [DOI] [PubMed] [Google Scholar]
  12. Outzen H. C., Corrow D., Shultz L. D. Attenuation of exogenous murine mammary tumor virus virulence in the C3H/HeJ mouse substrain bearing the Lps mutation. J Natl Cancer Inst. 1985 Nov;75(5):917–923. doi: 10.1093/jnci/75.5.917. [DOI] [PubMed] [Google Scholar]
  13. Rohan T. E., Bain C. J. Diet in the etiology of breast cancer. Epidemiol Rev. 1987;9:120–145. doi: 10.1093/oxfordjournals.epirev.a036299. [DOI] [PubMed] [Google Scholar]
  14. Sarkar N. H., Fernandes G., Telang N. T., Kourides I. A., Good R. A. Low-calorie diet prevents the development of mammary tumors in C3H mice and reduces circulating prolactin level, murine mammary tumor virus expression, and proliferation of mammary alveolar cells. Proc Natl Acad Sci U S A. 1982 Dec;79(24):7758–7762. doi: 10.1073/pnas.79.24.7758. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Shrivastav T. G., Pandey P. K., Kumari G. L. Enzyme immunosorbent assay of prolactin with penicillinase as label. Clin Chem. 1988 Nov;34(11):2205–2207. [PubMed] [Google Scholar]
  16. Topper Y. J., Freeman C. S. Multiple hormone interactions in the developmental biology of the mammary gland. Physiol Rev. 1980 Oct;60(4):1049–1106. doi: 10.1152/physrev.1980.60.4.1049. [DOI] [PubMed] [Google Scholar]
  17. Welsch C. W., Gribler C. Prophylaxis of spontaneously developing mammary carcinoma in C3H-HeJ female mice by suppression of prolactin. Cancer Res. 1973 Nov;33(11):2939–2946. [PubMed] [Google Scholar]
  18. Welsch C. W., Nagasawa H. Prolactin and murine mammary tumorigenesis: a review. Cancer Res. 1977 Apr;37(4):951–963. [PubMed] [Google Scholar]
  19. Yanai R., Nagasawa H. Inhibition of mammary tumorigenesis by ergot alkaloids and promotion of mammary tumorigenesis by pituitary isografts in adreno-ovariectomized mice. J Natl Cancer Inst. 1972 Mar;48(3):715–719. [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES